301015SZSE
🚨 Material Event

Notice of Convening the Second Extraordinary General Meeting of Shareholders in 2026

Qingdao Baheal Medical INC.··10 pages

✨ AI Summary

Qingdao Baiyang Pharmaceutical Co., Ltd. will hold its second extraordinary general meeting of shareholders on June 26, 2026. The meeting will review proposals related to the company's H-share issuance and listing in Hong Kong, among other matters. Shareholders can attend in person or vote online.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 301015 Bond Code: 123194 Stock Abbreviation: Baiyang Pharmaceutical Bond Abbreviation: Baiyang Convertible Bond Announcement Number: 2026-050

Qingdao Baiyang Pharmaceutical Co., Ltd. Notice of Convening the Second Extraordinary General Meeting of Shareholders in 2026

The Company and all members of the Board of Directors guarantee that the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

Important Notice: The Eighth Meeting of the Fourth Board of Directors of Qingdao Baiyang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was held on June 10, 2026. The meeting decided to convene the Second Extraordinary General Meeting of Shareholders in 2026 on June 26, 2026 (Friday). The relevant matters of the meeting are hereby notified as follows:

I. Basic Information on the Convening of the Meeting

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.